Search

Your search keyword '"Independent regulatory commissions -- Health aspects"' showing total 286 results
Start Over Descriptor "Independent regulatory commissions -- Health aspects"
286 results on '"Independent regulatory commissions -- Health aspects"'

1. ETHYLENE OXIDE EXPOSURE AND HUMAN HEALTH RISK

Author

Lebeau, Alex

Subjects
Independent regulatory commissions -- Health aspects, Ethylene -- Health aspects, Ethylene oxide -- Health aspects, Non-governmental organizations -- Health aspects, United States. Environmental Protection Agency
Abstract

In recent years, acute awareness has been focused on ethylene oxide health impacts by community stakeholders, regulators, and attorneys across the United States. Following several investigations in the 2010s, ethylene [...]

Published
2024

2. Milestone Approval to Steady Stream, Gene Editing Revs Up: The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies

Author

Mirasol, Feliza

Subjects
Biological products industry -- Health aspects, Independent regulatory commissions -- Health aspects, Genes -- Health aspects, Biotechnology -- Health aspects, Messenger RNA -- Health aspects, Vaccines -- Health aspects, Biotechnology industry, Business, Pharmaceuticals and cosmetics industries
Abstract

With the rise of nucleic acid-based therapeutics, such as the mRNA vaccines, biopharma developers are working toward the next big breakthrough in personalized medicines. Over the past couple of years, [...]

Published
2024

3. Covid-19 and flu cases surge as NHS bosses give advice on staying well this Christmas; Flu is about to rise after children break up from school for Christmas as experts say some relatives should avoid brussel sprouts and take painkillers after their turkey

Subjects
Vaccination -- Health aspects, Independent regulatory commissions -- Health aspects, Influenza vaccines -- Health aspects, Influenza -- Health aspects, General interest, News, opinion and commentary
Abstract

Byline: By, Martin Bagot Flu infections surging among children are about to start rising among adults as children break up for Christmas. The NHS is taking pop-up vaccination clinics to [...]

Published
2024

6. Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

Subjects
Independent regulatory commissions -- Health aspects, Bacterial infections -- Health aspects, Infection -- Health aspects, Clinical trials -- Health aspects, Antibiotics -- Product development, General interest, News, opinion and commentary
Abstract

STATEN ISLAND, N.Y: Acurx Pharmaceuticals, Inc. has issued the following news release: Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ('Acurx' or the 'Company'), a late-stage biopharmaceutical company developing a new class of [...]

Published
2024

7. Regulatory update: Transcript of Meeting on the Medical Uses of Isotopes Meeting November 4, 2024, Pages 1 - 142

Subjects
United States. Nuclear Regulatory Commission -- Officials and employees, Independent regulatory commissions -- Health aspects, News, opinion and commentary, International Atomic Energy Agency -- Officials and employees, Microsoft Teams (Messaging software) -- Health aspects
Abstract

Washington: The United States Nuclear Regulatory Commission has issued the following document: Official Transcript of Proceedings NUCLEAR REGULATORY COMMISSION Title: Advisory Committee on the Medical Uses of Isotopes Location: teleconference [...]

Published
2024

8. Richard Tice ask the Secretary of State for Health and Social Care, what information his Department holds on the potential thyroid cancer risk from Mounjaro; when his Department received this information

Subjects
United States. Food and Drug Administration, Independent regulatory commissions -- Health aspects, Surveillance equipment -- Health aspects, Thyroid cancer -- Risk factors, Business, international, Mounjaro (Medication) -- Health aspects
Abstract

London: UK Parliament has issued the following written answer: Answer Karin Smyth Answered on 18 November 2024 The Medicines and Healthcare products Regulatory Agency's (MHRA) role is to continually monitor [...]

Published
2024

9. FDA ruling on ecstasy for PTSD is a bad trip for suffering patients

Subjects
United States. Food and Drug Administration, Ecstasy (Drug) -- Health aspects, Independent regulatory commissions -- Health aspects, Drug approval -- Health aspects, Post-traumatic stress disorder -- Drug therapy, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Tom Shroder This month, the Food and Drug Administration denied a new drug application by Lykos Therapeutics that would have allowed the first legal medical use of a psychedelic [...]

Published
2024

10. Raising the standard in therapy with psychedelics

Subjects
Independent regulatory commissions -- Health aspects, Mental health -- Health aspects, Psychotherapy -- Health aspects, Post-traumatic stress disorder -- Health aspects, Evidence-based medicine -- Health aspects, Health, Psychology and mental health
Abstract

2024 DEC 23 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Psychedelic substances like psilocybin (found in magic mushrooms), MDMA (commonly known as ecstasy), [...]

Published
2024

11. Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer

Subjects
United States. Food and Drug Administration, Independent regulatory commissions -- Health aspects, Mammography -- Health aspects, Breast cancer -- Risk factors, General interest, News, opinion and commentary
Abstract

SEATTLE: Atossa Therapeutics, Inc. has issued the following news release: Atossa Therapeutics, Inc. (Nasdaq: ATOS) ('Atossa' or the 'Company'), announced its support of the U.S. Food and Drug Administration (FDA) [...]

Published
2024

12. Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer

Subjects
Independent regulatory commissions -- Health aspects, Cancer -- Diagnosis, Cancer patients -- Health aspects, Mammography -- Health aspects, Health care industry -- Health aspects, Breast cancer -- Risk factors, Health care industry, Banking, finance and accounting industries, Business
Abstract

SEATTLE, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ('Atossa' or the 'Company'), today announced its support of the U.S. Food and Drug Administration (FDA) for issuing [...]

Published
2024

13. Federal Energy Regulatory Commission Issues Letter to Avista Corporation concluding that the 02|07|2024 fish mortality event will not be considered a violation of license requirements for the Spokane River Hydroelectric Project under P-2545

Subjects
United States. Federal Energy Regulatory Commission, Avista Corp., Fishes -- Health aspects, Independent regulatory commissions -- Health aspects, Electric utilities -- Health aspects, Fish kills -- Health aspects, News, opinion and commentary
Abstract

Washington: Federal Energy Regulatory Commission Issues the following General Correspondence: FEDERAL ENERGY REGULATORY COMMISSION Washington, D. C. 20426 OFFICE OF ENERGY PROJECTS Project No. 2545-204 - Idaho and Washington Spokane [...]

Published
2024

14. Ethris receives UK MHRA nod to begin phase I study of ETH47, a first-in-class inhaled mRNA for respiratory viral infections

Subjects
Independent regulatory commissions -- Health aspects, Messenger RNA -- Health aspects, Infection -- Health aspects, Clinical trials -- Health aspects, Vaccines -- Product development, Pharmaceuticals and cosmetics industries
Abstract

Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, announced that it has received approval from the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) [...]

Published
2023

15. Up to 1.6 million people have had the flu so far this season

Author

Bowers, Lois A.

Subjects
Independent regulatory commissions -- Health aspects, Influenza vaccines -- Health aspects, Influenza -- Health aspects, Business, Health, Health care industry, Seniors
Abstract

Up to 1.6 million people were sickened with influenza from Oct 1. through Nov. 11, the Centers for Disease Control and Prevention https://www.cdc.gov/flu/about/burden/preliminary-in-season-estimates.htm. The agency published preliminary estimates based on [...]

Published
2023

16. Red Alert

Subjects
Independent regulatory commissions -- Health aspects, Food labeling -- Health aspects, Attention-deficit hyperactivity disorder -- Health aspects
Abstract

Health Digest / WELLNESS FOR BODY & MIND / HEALTH Digest WELLNESS FOR BODY & MIND Red Alert Some U.S. states may soon require warning labels about certain food dyes. [...]

Published
2023

17. Where That Color Comes From

Subjects
Independent regulatory commissions -- Health aspects, Attention-deficit hyperactivity disorder -- Health aspects
Abstract

BY Debby Waldman ILLUSTRATIONS BY Kate Traynor THAT ARTIFICIAL FOOD dyes are unhealthy is not news. Some of the most common additives—used to give color to everything from M&M's to [...]

Published
2023

18. Regulatory update: ACMUI, Subcommittee on Extravasations, Draft Report, June 11, 2024

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: The United States Nuclear Regulatory Commission has issued the following document: U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Extravasations Subcommittee [...]

Published
2024

19. Regulatory update: Advisory Committee on Medical Uses of Isotopes (ACMUI) Subcommittee on Extravasations Final Report June 17 2024

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: The United States Nuclear Regulatory Commission has issued the following document: U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Extravasations Subcommittee [...]

Published
2024

20. Regulatory update: Advisory Committee on the Medical Uses of Isotopes (ACMUI), Subcommittee on Extravasations, Draft Report, June 11, 2024

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: The United States Nuclear Regulatory Commission has issued the following document: U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Extravasations Subcommittee [...]

Published
2024

21. Corporate information: IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - GMP Certificate Issued By Brazilian Health Regulatory Agency (ANVISA) (Update on 11-05-24)

Subjects
IOL Chemicals and Pharmaceuticals Ltd., Independent regulatory commissions -- Health aspects, Pharmaceutical industry -- Health aspects, General interest, News, opinion and commentary
Abstract

Mumbai: IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - GMP Certificate Issued By Brazilian Health Regulatory Agency (ANVISA) The complete document can be viewed at this link: [...]

Published
2024

22. UK MHRA authorizes from SK Chemicals' SKYCovion Covid-19 vaccine

Subjects
Independent regulatory commissions -- Health aspects, Vaccines -- Health aspects, Pharmaceuticals and cosmetics industries
Abstract

SKYCovion, the Covid-19 vaccine developed by SK Chemicals, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). It becomes the 8th Covid-19 vaccine authorised by the UK's [...]

Published
2023

23. THE ADMINISTRATION ANNOUNCES INDEFINITE DELAY IN THE FINALIZATION OF THE FDA RULES PROHIBITING MENTHOL CIGARETTES AND ALL FLAVORS IN CIGARS; PROLONGING PUBLIC HEALTH DISPARITIES

Subjects
United States. Food and Drug Administration, Independent regulatory commissions -- Health aspects, Public health -- Health aspects, Cigarettes -- Product discontinuation, News, opinion and commentary
Abstract

WASHINGTON, D.C. -- The following information was released by the American Cancer Society Cancer Action Network (ACS CAN): ACS CAN says White House must act to reduce tobacco-related cancer disparities [...]

Published
2024

24. Regulatory update: United States Nuclear Regulatory Commission has submitted (WIGGINS E J ) Notification of contract execution,Mod 1 to 'Medical Use of Radionuclides for State Regulatory Personnel.' Contractor: Baylor College of Medicine

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, Medical colleges -- Health aspects, Contractors -- Health aspects, Contract agreement, News, opinion and commentary, Baylor College of Medicine
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: NOTKICATION OF CONTRACT EXECL 10N SiroCter CONTRACT BASED ON: TO: AUTHORIZATION NUMBER / Tit /e/ RFPA Mo. 05P-79-301 . [...]

Published
2024

25. Regulatory update: United States Nuclear Regulatory Commission has submitted ( NRC|OCM) M240409B: Transcript - Meeting with Advisory Committee on the Medical Uses of Isotopes

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION + + + + + MEETING WITH ADVISORY COMMITTEE ON THE MEDICAL [...]

Published
2024

26. Regulatory update: United States Nuclear Regulatory Commission has submitted (HENDRIE J M ) Endorses Secretary J Califano 790802 recommendations re rept of Interagency Task Force on Health Effects of Ionizing Radiation.Forwards Califano 790802 recommendations on radiation exposure

Subjects
United States. Nuclear Regulatory Commission, Task forces -- Health aspects, Independent regulatory commissions -- Health aspects, Radiation -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: The President The White House Washington, D. C. 20500 Dear Mr. President: On August 2,1979, Secretary Califano sent to [...]

Published
2024

27. Regulatory update: United States Nuclear Regulatory Commission has submitted (NRC|ACMUI ) Advisory Committee on the Medical Use of Isotopes (ACMUI), Subcommittee onAkesis Galaxy RTi Draft Licensing Guidance, Draft Report, March 6, 2024

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: 1 of 3 U.S. Nuclear Regulatory Commission Advisory Committee on the Medical Use of Isotopes Subcommittee Review and Comments [...]

Published
2024

28. Sentynl Therapeutics Receives MHRA Authorization of NULIBRY (fosdenopterin) for Treatment of MoCD Type A in Great Britain

Subjects
United States. Food and Drug Administration, Independent regulatory commissions -- Health aspects, Drug approval -- Health aspects, Business, News, opinion and commentary, Nulibry (Medication) -- Health aspects
Abstract

NULIBRY is the first and only treatment in Great Britain for patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening genetic disorder that often progresses rapidly in infants [...]

Published
2024

29. Regulatory update: United States Nuclear Regulatory Commission has submitted ( NRC|OCM) M240409B: Agenda - Meeting with Advisory Committee on the Medical Uses of Isotopes

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: AGENDA Title: MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES (Public Meeting) Purpose: Provide an opportunity [...]

Published
2024

30. Regulatory update: United States Nuclear Regulatory Commission has submitted (SHAW M ) Forwards comments on SARs requested by AEC 690122,690207 & 690314 ltrs

Subjects
United States. Nuclear Regulatory Commission, Duquesne Light Co., Independent regulatory commissions -- Health aspects, Electric utilities -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: Pe te r A. Mcrris, 'tt ec tor Division of Reactuc Licensing SAFEri CALYSIS REPORTS Re fer ence is [...]

Published
2024

31. Combined antibiotic approved to treat adult patients with severe infections of the urinary tract and hospital-acquired pneumonia

Subjects
Urinary tract infections -- Health aspects, Independent regulatory commissions -- Health aspects, Tazobactam -- Health aspects, Adults -- Health aspects, Business, international, Exblifep (Medication) -- Health aspects
Abstract

London: UK Government has issued the following news release: The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion) The Medicines [...]

Published
2024

32. COMBINED ANTIBIOTIC APPROVED TO TREAT ADULT PATIENTS WITH SEVERE INFECTIONS OF THE URINARY TRACT AND HOSPITAL-ACQUIRED PNEUMONIA

Subjects
Urinary tract infections -- Health aspects, Independent regulatory commissions -- Health aspects, Tazobactam -- Health aspects, Adults -- Health aspects, News, opinion and commentary, Exblifep (Medication) -- Health aspects
Abstract

LONDON -- The following information was released by the UK Government: The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion) [...]

Published
2024

33. Regulatory update: United States Nuclear Regulatory Commission has submitted (NRC|OCM) M240409B: Slides - Meeting with Advisory Committee on the Medical Uses of Isotopes

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, Radiotherapy -- Health aspects, Radioactive substances -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: Overview of ACMUI Activities Hossein Jadvar, M.D., Ph.D. ACMUI Chair/Nuclear Medicine Physician April 9, 2024 Today's Agenda * Hossein [...]

Published
2024

34. WHITE HOUSE AGAIN MISSES DEADLINE TO FINALIZE FDA RULES PROHIBITING MENTHOL CIGARETTES AND ALL FLAVORS IN CIGARS; REFUSES TO ADDRESS PUBLIC HEALTH DISPARITIES

Subjects
United States. Food and Drug Administration, Regulatory compliance -- Health aspects, Independent regulatory commissions -- Health aspects, Public health -- Health aspects, Cigarettes -- Product discontinuation, News, opinion and commentary
Abstract

WASHINGTON, D.C. -- The following information was released by the American Cancer Society Cancer Action Network (ACS CAN): ACS CAN says White House must act to reduce tobacco-related cancer and [...]

Published
2024

35. Regulatory update: United States Nuclear Regulatory Commission has submitted (Chazell R E ) COMSECY-23-0016: Enclosure 1 - Charter for the Advisory Committee on The Medical Uses of Isotopes (Clean)

Subjects
United States. Nuclear Regulatory Commission -- Officials and employees, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES 1. Committee's Official [...]

Published
2024

36. Regulatory update: United States Nuclear Regulatory Commission has submitted (Chazell R E ) COMSECY-23-0016: Enclosure 2 - Charter for the Advisory Committee on The Medical Uses of Isotopes (Draft)

Subjects
United States. Nuclear Regulatory Commission -- Officials and employees, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES 1. Committee's Official [...]

Published
2024

37. Regulatory update: United States Nuclear Regulatory Commission has submitted ( Chazell R E) Charter for the Advisory Committee on the Medical Uses of Isotopes

Subjects
United States. Nuclear Regulatory Commission -- Officials and employees, Independent regulatory commissions -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES 1. Committee's Official [...]

Published
2024

38. Federal Energy Regulatory Commission Issues Letter to Loup River Public Power District discussing the 07|27|2023 et al. reports of elevated water temperature and fish mortality etc. for the Loup River Hydroelectric Project under P-1256

Subjects
United States. Fish and Wildlife Service, United States. Federal Energy Regulatory Commission, Fishes -- Health aspects, Independent regulatory commissions -- Health aspects, Water-power -- Health aspects, News, opinion and commentary
Abstract

Washington: Federal Energy Regulatory Commission Issues the following General Correspondence : FEDERAL ENERGY REGULATORY COMMISSION Washington, D. C. 20426 OFFICE OF ENERGY PROJECTS Project No. 1256-078, -079, -080 --Nebraska Loup [...]

Published
2024

40. FDA proposes ban on hair-straightening products containing formaldehyde; Proposal comes after study showing 50% increase in risk of uterine cancer for users of straighteners, who are frequently Black women

Subjects
Oncology, Experimental -- Health aspects, Women -- Health aspects, Women, Black -- Health aspects, Independent regulatory commissions -- Health aspects, Formaldehyde -- Health aspects, Cancer -- Risk factors -- Research, News, opinion and commentary
Abstract

Byline: Tom Perkins The Biden administration is proposing banning hair straighteners that contain formaldehyde, products in the US which are largely used by Black women. The move comes after years [...]

Published
2023

43. Halucenex Life Sciences targets Australian market following TGA decision

Subjects
Ecstasy (Drug) -- Health aspects, Independent regulatory commissions -- Health aspects, Mental health -- Health aspects, Health
Abstract

CANNABIS INDUSTRY INSIGHT-(C)2023 M2 COMMUNICATIONS Creso Pharma Limited (ASX:CPH, FRA:1X8) has said that its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc., is looking at opportunities to register its synthetic psilocybin [...]

Published
2023

44. Regulatory update: United States Nuclear Regulatory Commission has submitted (Shelton B J ) Concurrence in the Revision of 10 CFR Part 35, Medical Use of Byproduct Material, Final Rule

Subjects
Independent regulatory commissions -- Health aspects, Chief information officers -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: April 18, 2000 MEMORANDUM TO:Catherine Haney Rulemaking and Guidance Branch Division of Industrial and Medical Nuclear Safety Office of [...]

Published
2024

45. Oncology Clinical Trials During the COVID-19 Pandemic

Author

Gongora, Aline Bobato Lara, Jardim, Denis Leonardo Fontes, and Bastos, Diogo Assed

Subjects
United States. Food and Drug Administration, Infection control -- Health aspects, Epidemics -- Brazil, Independent regulatory commissions -- Health aspects, Mortality -- Brazil, Clinical trials -- Health aspects, Coronaviruses -- Health aspects, Health
Abstract

KEY POINTS: The coronavirus disease 2019 (COVID-19) pandemic has rapidly spread all over the world in the past several months. No effective treatment for COVID-19 has been established. High transmissibility and considerable mortality rates have forced many national governments to implement quarantine measures. Many patients with cancer rely on clinical trials to receive their oncologic care, but the routine conduct of clinical trials has substantially changed because of the COVID-19 pandemic. The oncology research community should implement formal policies based on the guidance given from regulatory agencies, with the goal of minimizing the risks of COVID-19 infection while maintaining appropriate oncologic treatments for patients during this pandemic., Introduction As of June 2020, coronavirus disease 2019 (COVID-19) has affected almost 7 million individuals globally and caused more than 400,000 deaths worldwide. (1) In addition to those lives lost [...]

Published
2020

46. Regulatory update: United States Nuclear Regulatory Commission has submitted ( Thevenot L I) Comment (016) from Laura I. Thevenot on behalf of the American Society for Radiation Oncology on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material

Subjects
United States. Nuclear Regulatory Commission, Societies -- Health aspects, Independent regulatory commissions -- Health aspects, Radiation -- Health aspects, Associations, institutions, etc. -- Health aspects, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: 12/15/23, 12:02 PM blob:https://www.fdms.gov/134657a8-832d-4828-8b89-b97025aa3efb blob:https://www.fdms.gov/134657a8-832d-4828-8b89-b97025aa3efb 1/1 PUBLIC SUBMISSION As of: 12/15/23, 12:01 PM Received: December 15, 2023 Status: Pending_Post [...]

Published
2023

47. Regulatory update: United States Nuclear Regulatory Commission has submitted (AL Mallah M ) Comment (017) from Mouaz Al Mallah on behalf of the American Society of Nuclear Cardiology on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material

Subjects
United States. Nuclear Regulatory Commission -- Public relations, Cardiology -- Health aspects, Trade and professional associations -- Health aspects, Independent regulatory commissions -- Health aspects, Company public relations, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: 12/15/23, 12:05 PM blob:https://www.fdms.gov/d0b7706a-aa4a-4f80-b516-4111cb9adc81 blob:https://www.fdms.gov/d0b7706a-aa4a-4f80-b516-4111cb9adc81 1/1 PUBLIC SUBMISSION As of: 12/15/23, 12:05 PM Received: December 15, 2023 Status: Pending_Post [...]

Published
2023

48. Regulatory update: United States Nuclear Regulatory Commission has submitted (Peterson P ) Comment (013) from the Organization of Agreement States on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material

Subjects
United States. Nuclear Regulatory Commission, Independent regulatory commissions -- Health aspects, Company public relations, News, opinion and commentary
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: From: Peterson - CDPHE, Phillip To: Maryann Ayoade; Adelaide Giantelli Cc: OAS Executive Board Subject: [External_Sender] STC-23-049 comments Date: [...]

Published
2023

49. Regulatory update: United States Nuclear Regulatory Commission has submitted (Bello J A ) Comment (010) from Jacqueline A. Bello on behalf of the American College of Radiology on PR-35 - Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material

Subjects
United States. Nuclear Regulatory Commission -- Public relations, Radiology -- Health aspects, Independent regulatory commissions -- Health aspects, Radiology, Medical -- Health aspects, Company public relations, News, opinion and commentary, American College of Radiology -- Public relations
Abstract

Washington: United States Nuclear Regulatory Commission has issued the following document: PUBLIC SUBMISSION As of: 12/13/23, 9:09 AM Received: December 12, 2023 Status: Pending_Post Tracking No. lq2-tl6b-ht69 Comments Due: December [...]

Published
2023

50. Acurx's Antibiotic shows all patients with clinical cure remained infection-free after treatment

Subjects
Independent regulatory commissions -- Health aspects, Infection -- Care and treatment, Antibiotics -- Health aspects, General interest, News, opinion and commentary
Abstract

Acurx Pharmaceuticals Inc ACXP published Phase 2b results showing that 100% of patients with C. difficile infection (CDI) who were clinically cured (CC) with ibezapolstat also had sustained clinical cure [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results